Ellen Wright Clayton is an internationally respected leader in the field of health law, focusing on the conduct of genomics research and its translation to clinical care while protecting the interests of patients and communities. She is currently co-principal investigator of a transdisciplinary Center for Excellence in Ethical, Legal and Social Implications Research study addressing genomic privacy and recently completed another ESLI study analyzing legal issues in liability, quality, privacy and access, and the clinical-research interface, all with the goal of developing more effective solutions. She has published two books and more than 200 scholarly articles and chapters in medical journals, interdisciplinary journals and law journals on the intersection of law, medicine and public health. She has also collaborated with faculty and students throughout Vanderbilt and in many institutions around the country and the world on interdisciplinary research projects and helped to develop policy statements for numerous national and international organizations. An active participant in policy debates, Professor Clayton has advised the National Institutes of Health and other federal and international bodies on an array of topics ranging from children's health to the ethical conduct of research involving human subjects. Her teaching interests include law and genomics, bioethics and law, reproductive rights, and public health and research ethics. Clayton has worked on numerous projects for the National Academy of Medicine, including serving as a member of its Advisory Council and chair of the Board on Population Health and Public Health Practice. She is currently co-chair of the Report Review Committee of the National Academies of Sciences, Engineering and Medicine, in that role supervising the Academies’ work on COVID-19. She is an elected Fellow of the American Academy for the Advancement of Science.